(2R,3S,4S,5R,6S)-2-Ethyl-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol

(2R,3S,4S,5R,6S)-2-ethyl-6-[6-(3-methylbut-2-enylamino)purin-9-yl]oxane-3,4,5-triol

MIBAUVZDWWWONW-HFVZKWEFSA-N CHEBI:184733 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: MIBAUVZDWWWONW-HFVZKWEFSA-N
InChI Key: MIBAUVZDWWWONW-HFVZKWEFSA-N
IUPAC name: (2R,3S,4S,5R,6S)-2-ethyl-6-[6-(3-methylbut-2-enylamino)purin-9-yl]oxane-3,4,5-triol
Preferred name: (2R,3S,4S,5R,6S)-2-Ethyl-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol
INN name: —
Synonym: —
ChEBI: CHEBI:184733

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)

Observed in differential profiles

G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47